Naoko Tsuyama

1.6k total citations
44 papers, 605 citations indexed

About

Naoko Tsuyama is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Naoko Tsuyama has authored 44 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pathology and Forensic Medicine, 21 papers in Oncology and 14 papers in Neurology. Recurrent topics in Naoko Tsuyama's work include Lymphoma Diagnosis and Treatment (34 papers), CNS Lymphoma Diagnosis and Treatment (12 papers) and Viral-associated cancers and disorders (11 papers). Naoko Tsuyama is often cited by papers focused on Lymphoma Diagnosis and Treatment (34 papers), CNS Lymphoma Diagnosis and Treatment (12 papers) and Viral-associated cancers and disorders (11 papers). Naoko Tsuyama collaborates with scholars based in Japan, Taiwan and India. Naoko Tsuyama's co-authors include Kengo Takeuchi, Seiji Sakata, Kiyohiko Hatake, Akito Dobashi, Kana Sakamoto, Satoko Baba, Kyoko Ueda, Reimi Asaka, Noriko Nishimura and Yasuhito Terui and has published in prestigious journals such as Blood, PLoS ONE and Leukemia.

In The Last Decade

Naoko Tsuyama

40 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoko Tsuyama Japan 13 380 331 123 117 108 44 605
Zhen Fan United States 6 392 1.0× 342 1.0× 135 1.1× 129 1.1× 90 0.8× 8 586
Suguru Fukuhara Japan 14 433 1.1× 260 0.8× 137 1.1× 183 1.6× 80 0.7× 83 603
Maricer P. Escalón United States 12 408 1.1× 263 0.8× 81 0.7× 117 1.0× 208 1.9× 22 724
Jean‐Marc Schiano de Colella France 13 263 0.7× 261 0.8× 134 1.1× 99 0.8× 194 1.8× 41 600
Manuel F. Rosado United States 10 333 0.9× 249 0.8× 113 0.9× 97 0.8× 87 0.8× 14 491
Parth Desai United States 12 295 0.8× 289 0.9× 115 0.9× 189 1.6× 58 0.5× 52 576
Kyle Perry United States 10 336 0.9× 252 0.8× 96 0.8× 106 0.9× 45 0.4× 29 603
Adam M. Petrich United States 17 554 1.5× 388 1.2× 169 1.4× 221 1.9× 127 1.2× 57 902
Eva Cristóbal Spain 15 371 1.0× 276 0.8× 72 0.6× 160 1.4× 84 0.8× 29 715
Julien Lazarovici France 10 335 0.9× 435 1.3× 65 0.5× 94 0.8× 189 1.8× 36 684

Countries citing papers authored by Naoko Tsuyama

Since Specialization
Citations

This map shows the geographic impact of Naoko Tsuyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Tsuyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Tsuyama more than expected).

Fields of papers citing papers by Naoko Tsuyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoko Tsuyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Tsuyama. The network helps show where Naoko Tsuyama may publish in the future.

Co-authorship network of co-authors of Naoko Tsuyama

This figure shows the co-authorship network connecting the top 25 collaborators of Naoko Tsuyama. A scholar is included among the top collaborators of Naoko Tsuyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoko Tsuyama. Naoko Tsuyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinto, Daniel, Andrey Bychkov, Naoko Tsuyama, Junya Fukuoka, & Catarina Eloy. (2023). Real-World Implementation of Digital Pathology: Results From an Intercontinental Survey. Laboratory Investigation. 103(12). 100261–100261. 19 indexed citations
2.
Tsuyama, Naoko, Masaaki Noguchi, Reimi Asaka, et al.. (2022). Hodgkinoid histiocytosis: an atypical nodal CD30 and S100‐positive histiocytosis with eosinophilia. Histopathology. 81(3). 371–379. 3 indexed citations
3.
4.
Nishimura, Noriko, Hirofumi Yamauchi, Naoko Tsuyama, et al.. (2020). Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCL. Clinical Lymphoma Myeloma & Leukemia. 21(3). 162–169. 5 indexed citations
5.
Sakamoto, Kana, Ryohei Katayama, Reimi Asaka, et al.. (2018). Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response. Leukemia. 32(12). 2590–2603. 43 indexed citations
6.
Yokoyama, Masahiro, Hirofumi Yamauchi, Naoko Tsuyama, et al.. (2017). Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenance. Annals of Hematology. 97(2). 289–297. 2 indexed citations
7.
Nishimura, Noriko, Reimi Asaka, Kengo Takeuchi, et al.. (2017). Quantitative analysis of MYD88 L265P mutations by digital PCR is an independent prognostic factor for CNS relapse as well as systemic relapse and poor outcome. Hematological Oncology. 35(S2). 277–277.
8.
Yokoyama, Masaru, Y. Terui, Noriko Nishimura, et al.. (2017). Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma. Blood Cancer Journal. 7(4). e558–e558. 22 indexed citations
9.
Tsuyama, Naoko, Daisuke Ennishi, Masahiro Yokoyama, et al.. (2017). Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases ofde novodiffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas. Oncotarget. 8(20). 33487–33500. 27 indexed citations
10.
Tsuyama, Naoko, Reimi Asaka, Akito Dobashi, et al.. (2017). Epstein‐Barr virus‐negative extranodal “true” natural killer‐cell lymphoma harbouring a KDM6A mutation. Hematological Oncology. 36(1). 328–335. 8 indexed citations
11.
Terui, Yasuhito, Kengo Takeuchi, Naoko Tsuyama, et al.. (2016). Absolute CD4+ T-Cell Count Predicts Survival in Diffuse Large B-Cell Lymphoma. Blood. 128(22). 3053–3053. 1 indexed citations
12.
Nishimura, Noriko, Y. Terui, Atsushi Takahashi, et al.. (2015). Multiple myeloma as a second primary malignancy; one fourth of patients had prior history of other malignances. Clinical Lymphoma Myeloma & Leukemia. 15. e113–e113. 2 indexed citations
13.
Terui, Y., M. Yokoyama, Yuji Mishima, et al.. (2014). Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma. Haematologica. 100(1). 87–90. 15 indexed citations
14.
Sakata, Seiji, Naoko Tsuyama, & Kengo Takeuchi. (2014). Pathology of Indolent B-Cell Neoplasms Other than Follicular Lymphoma. Journal of Clinical and Experimental Hematopathology. 54(1). 11–22. 5 indexed citations
15.
Yamamoto, Eri, Naoto Tomita, Seiji Sakata, et al.. (2013). MIB‐1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy. Cancer Science. 104(12). 1670–1674. 12 indexed citations
16.
Takahashi, Hiroyuki, Naoto Tomita, Seiji Sakata, et al.. (2013). Prognostic significance of programmed cell death‐1‐positive cells in follicular lymphoma patients may alter in the rituximab era. European Journal Of Haematology. 90(4). 286–290. 18 indexed citations
17.
18.
Nakano, Kenji, Takeshi Yuasa, Nao Nishimura, et al.. (2012). Feasibility and Efficacy of Combined Cisplatin and Irinotecan Chemotherapy for Poorly Differentiated Neuroendocrine Carcinomas. Japanese Journal of Clinical Oncology. 42(8). 697–703. 34 indexed citations
19.
Ueda, Kyoko, Yasuhito Terui, Masahiro Yokoyama, et al.. (2012). Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy. Leukemia & lymphoma. 54(9). 1928–1933. 10 indexed citations
20.
Suzuki, Keigo, Y. Terui, Noriko Nishimura, et al.. (2012). Prognostic Value of C-reactive Protein, Lactase Dehydrogenase and Anemia in Recurrent or Refractory Aggressive Lymphoma. Japanese Journal of Clinical Oncology. 43(1). 37–44. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhen Fan Breakdown of academic impact, for papers by Suguru Fukuhara Breakdown of academic impact, for papers by Maricer P. Escalón Breakdown of academic impact, for papers by Jean‐Marc Schiano de Colella Breakdown of academic impact, for papers by Manuel F. Rosado Breakdown of academic impact, for papers by Parth Desai Breakdown of academic impact, for papers by Kyle Perry Breakdown of academic impact, for papers by Adam M. Petrich Breakdown of academic impact, for papers by Eva Cristóbal Breakdown of academic impact, for papers by Julien Lazarovici
Rankless by CCL
2026